These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 16143528
1. Synthesis of potent and selective serotonin 5-HT1B receptor ligands. Huang Y, Bae SA, Roth BL, Laruelle M. Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4786-9. PubMed ID: 16143528 [Abstract] [Full Text] [Related]
2. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands. Siracusa MA, Salerno L, Modica MN, Pittalà V, Romeo G, Amato ME, Nowak M, Bojarski AJ, Mereghetti I, Cagnotto A, Mennini T. J Med Chem; 2008 Aug 14; 51(15):4529-38. PubMed ID: 18598015 [Abstract] [Full Text] [Related]
3. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide. Choi SK, Green D, Ho A, Klein U, Marquess D, Taylor R, Turner SD. J Med Chem; 2008 Jun 26; 51(12):3609-16. PubMed ID: 18507369 [Abstract] [Full Text] [Related]
6. Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands. Byrtus H, Pawłowski M, Duszyńska B, Wesołowska A, Chojnacka-Wójcik E, Bojarski AJ. Pol J Pharmacol; 2001 Jun 26; 53(4):395-401. PubMed ID: 11990087 [Abstract] [Full Text] [Related]
8. Identification of a series of benzoxazoles as potent 5-HT6 ligands. Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ. Bioorg Med Chem Lett; 2009 Feb 15; 19(4):1115-7. PubMed ID: 19152787 [Abstract] [Full Text] [Related]
12. Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties. Cappelli A, Gallelli A, Manini M, Anzini M, Mennuni L, Makovec F, Menziani MC, Alcaro S, Ortuso F, Vomero S. J Med Chem; 2005 May 19; 48(10):3564-75. PubMed ID: 15887964 [Abstract] [Full Text] [Related]
17. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. Sorbi C, Franchini S, Tait A, Prandi A, Gallesi R, Angeli P, Marucci G, Pirona L, Poggesi E, Brasili L. ChemMedChem; 2009 Mar 01; 4(3):393-9. PubMed ID: 19152363 [Abstract] [Full Text] [Related]
18. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation. Badarau E, Suzenet F, Bojarski AJ, Fînaru AL, Guillaumet G. Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1600-3. PubMed ID: 19237285 [Abstract] [Full Text] [Related]
19. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands. Prisinzano T, Law H, Dukat M, Slassi A, MaClean N, Demchyshyn L, Glennon RA. Bioorg Med Chem; 2001 Mar 15; 9(3):613-9. PubMed ID: 11310595 [Abstract] [Full Text] [Related]
20. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands. Heightman TD, Gaster LM, Pardoe SL, Pilleux JP, Hadley MS, Middlemiss DN, Price GW, Roberts C, Scott CM, Watson JM, Gordon LJ, Holland VA, Powles J, Riley GJ, Stean TO, Trail BK, Upton N, Austin NE, Ayrton AD, Coleman T, Cutler L. Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4370-4. PubMed ID: 16039851 [Abstract] [Full Text] [Related] Page: [Next] [New Search]